safety of tirzepatide Media Centre Efficacy and Safety of Tirzepatide
Description
Gastrointestinal side effectsnausea, vomiting, constipation, diarrheaoccur in 2550% of users depending on dose and individual factors

Dont use glass bottles, plastic water bottles, milk jugs or cartons, or soda cans

Exenatide repairs renal tubular epithelial cells damaged by a HFD by reversing SIRT1 downregulation, inhibiting reactive oxygen species, and blocking mitochondrial apoptosis [224], [225]

This article has an accompanied Plain Language Summary in the Supporting Information Data S1

MOUNJARO (tirzepatide), a GIP/GLP-1 dual receptor agonist, was compared to Trulicity (dulaglutide), a GLP-1 receptor agonist that showed a definitive cardiovascular benefit in the REWIND study
